Covid-19 a boon for healthcare and vaccine FEM went live on 6 April, and has already loaded around 10 million samples from the forensic laboratory administration system. Photo: iStock
Notwithstanding the incredible tragedy the pandemic has caused to families around the world, scientists can’t deny its long term benefits to the future of healthcare, particularly vaccines, and the treatment of viral infections. “Covid-19 vaccine research and the regulatory processes which guide the approval and introduction of vaccines and other medical products has led to more transparent discussions between regulatory authorities and other critical stakeholders such as civil society, patient’s user groups, media and policy makers.
“We expect to manufacture our COVID-19 vaccine as well as additional products within our mRNA vaccine portfolio at this facility,” CEO Stephane Bancel said in a statement. According to former Ethiopian Minister of Health and CEO of Big Win Philanthropy, Dr Kesete Admasu, new evidence from Mali and Burkina Faso shows that RTS,S could be an even more valuable tool than originally expected. This is becausethat shows that vaccine could help reduce malaria episodes by 70% when used with seasonal malaria chemoprevention.